Sun Xiuyun, Wang Jun, Yao Xia, Zheng Wen, Mao Yang, Lan Tianlong, Wang Liguo, Sun Yonghui, Zhang Xinyi, Zhao Qiuye, Zhao Jianguo, Xiao Rui-Ping, Zhang Xiuqin, Ji Guangju, Rao Yu
1Ministry of Education (MOE) Key Laboratory of Protein Sciences, School of Pharmaceutical Sciences, Tsinghua University, Beijing, 100084 China.
2MOE Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Beijing Advanced Innovation Center for Structural Biology, Tsinghua University, Beijing, 100084 China.
Cell Discov. 2019 Feb 5;5:10. doi: 10.1038/s41421-018-0079-1. eCollection 2019.
Although conventional genetic modification approaches for protein knockdown work very successfully due to the increasing use of CRISPR/Cas9, effective techniques for achieving protein depletion in adult animals, especially in large animals such as non-human primates, are lacking. Here, we report a chemical approach based on PROTACs technology that efficiently and quickly knocks down FKBP12 (12-kDa FK506-binding) protein globally in vivo. Both intraperitoneal and oral administration led to rapid, robust, and reversible FKBP12 degradation in mice. The efficiency and practicality of this method were successfully demonstrated in both large and small animals (mice, rats, Bama pigs, and rhesus monkeys). Furthermore, we showed this approach can also be applied to effectively knockdown other target proteins such as Bruton's tyrosine kinase (BTK). This chemical protein knockdown strategy provides a powerful research tool for gene function studies in animals, particularly in large animals, for which gene-targeted knockout strategies may remain unfeasible.
尽管由于CRISPR/Cas9的使用日益增加,传统的用于蛋白质敲低的基因编辑方法非常成功,但目前仍缺乏在成年动物,尤其是在非人类灵长类等大型动物中实现蛋白质耗竭的有效技术。在此,我们报道了一种基于PROTAC技术的化学方法,该方法能在体内高效、快速地全面敲低FKBP12(12 kDa FK506结合蛋白)。腹腔注射和口服给药均可导致小鼠体内FKBP12快速、显著且可逆的降解。该方法的有效性和实用性在大小动物(小鼠、大鼠、巴马猪和恒河猴)中均得到成功验证。此外,我们还表明该方法也可用于有效敲低其他靶蛋白,如布鲁顿酪氨酸激酶(BTK)。这种化学蛋白质敲低策略为动物尤其是大型动物的基因功能研究提供了一个强大的研究工具,而对于这些大型动物,基因靶向敲除策略可能仍然不可行。